Among those patients who experienced a disease relapse after a prior diagnosis of primary breast cancer, all but three had a concordant HR-positive and HER2-negative tumor phenotype on both primary tumor and relapse biopsy. This evidence concerns the gene ERBB2 and breast carcinoma.